PMH4 COSTS AND CONSEQUENCES FOR METABOLIC SYNDROME, DIABETES AND CORONARY HEART DISEASE (CHD) RISK AMONG SCHIZOPHRENIA PATIENTS TREATED WITH ARIPIPRAZOLE VERSUS OLANZAPINE IN BRAZIL
Abstract
Authors
G Litalien M Nita E Golalves R Rached